[Clinical hematology and evolution of acute lymphoid leukemia subjected to fractionated antiblastic therapy (1962-1966)].
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000630:Aminopterin / Q000627:therapeutic use; D001772:Blood Cell Count; D001773:Blood Cells / Q000187:drug effects; D002648:Child; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000401:mortality; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D014750:Vincristine; D003520:Cyclophosphamide; D011239:Prednisolone; D015122:Mercaptopurine; D000630:Aminopterin; D008727:Methotrexate
Hematología clínica y evolución de las leucemias agudas linfoides sometidas a terapéutica antiblástica escalonada.